The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-{4-[5-[(3,4-Dimethoxy-phenyl)-methylamino]-1-(4-fluoro-phenyl)-1H-imidazol-2-ylsulfanylmethyl]-3,5-difluoro-phenyl}-prop-2-ynyl)-trimethylammonium iodide ID: ALA4086463
PubChem CID: 118577308
Max Phase: Preclinical
Molecular Formula: C31H32F3IN4O2S
Molecular Weight: 581.68
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(N(C)c2cnc(SCc3c(F)cc(C#CC[N+](C)(C)C)cc3F)n2-c2ccc(F)cc2)cc1OC.[I-]
Standard InChI: InChI=1S/C31H32F3N4O2S.HI/c1-36(24-13-14-28(39-5)29(18-24)40-6)30-19-35-31(37(30)23-11-9-22(32)10-12-23)41-20-25-26(33)16-21(17-27(25)34)8-7-15-38(2,3)4;/h9-14,16-19H,15,20H2,1-6H3;1H/q+1;/p-1
Standard InChI Key: NIERUOACYBGPDK-UHFFFAOYSA-M
Molfile:
RDKit 2D
42 44 0 0 0 0 0 0 0 0999 V2000
14.8704 -3.0624 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
17.1321 -4.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3149 -4.9362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7235 -5.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6528 -4.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0009 -4.8594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3306 -4.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5711 -3.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3881 -3.5968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0119 -5.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7263 -6.0724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7373 -6.8895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0380 -7.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3235 -6.9145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3126 -6.0975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0490 -8.1276 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.4358 -4.6084 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.0334 -4.0546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8123 -4.2951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4140 -3.7372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1929 -3.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3742 -4.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7766 -5.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9977 -5.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3960 -5.6472 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.2328 -2.9388 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.1573 -5.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9403 -5.2569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7192 -5.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1355 -4.1411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5579 -4.6566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9412 -4.1204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4017 -5.4588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0993 -3.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4835 -2.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7098 -3.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5554 -3.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1725 -4.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7846 -4.1240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6313 -4.9267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0975 -2.5158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3252 -2.7827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 3 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
5 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
13 16 1 0
6 10 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
17 18 1 0
24 25 1 0
20 26 1 0
27 28 3 0
28 29 1 0
3 30 1 0
29 3 1 0
22 27 1 0
5 17 1 0
7 31 1 0
31 32 1 0
31 33 1 0
32 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 32 1 0
39 40 1 0
37 39 1 0
41 42 1 0
36 41 1 0
M CHG 2 1 -1 3 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 581.68Molecular Weight (Monoisotopic): 581.2193AlogP: 6.42#Rotatable Bonds: 9Polar Surface Area: 39.52Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.15CX LogP: 2.79CX LogD: 2.79Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.13Np Likeness Score: -1.12
References 1. Lasalle M, Hoguet V, Hennuyer N, Leroux F, Piveteau C, Belloy L, Lestavel S, Vallez E, Dorchies E, Duplan I, Sevin E, Culot M, Gosselet F, Boulahjar R, Herledan A, Staels B, Deprez B, Tailleux A, Charton J.. (2017) Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance., 60 (10): [PMID:28414465 ] [10.1021/acs.jmedchem.6b01873 ]